Mechoulam R (1986) The pharmacohistory of Cannabis sativa. In: Mechoulam R
(ed) Cannabinoids as therapeutic agents. CRC Press, Boca Raton, pp 1– 19
Mechoulam R, Parker LA (2013) The endocannabinoid system and the brain. Annu Rev Psychol
64:21– 47
Merlin MD (1972) Man and marijuana: some aspects of their ancient relationship. Associated
University Presses, Cranbury
Mikuriya TH (1969) Marijuana in medicine: past, present and future. Calif Med 110(1):34– 40
Minelli A (1993) Biological systematics: the state of the art. Chapman & Hall, London
Mölleken H, Husmann H (1997) Cannabinoids in seed extracts ofCannabis sativacultivars. JIHA
4(2):73, 76– 79
Mölleken H, Theimer RR (1997) Survey of minor fatty acids inCannabis sativaL. fruits of
various origins. JIHA 4(1):13– 17
Montgomery B (1954) The bastfibers. In: Mauersberger HR (ed) Matthews’textilefibers, 6th edn.
Wiley, New York, pp 257– 359
Mukherjee A, Roy SC, De Bera S, Jiang HE, Li X, Li CS, Bera S (2008) Results of molecular
analysis of an archaeological hemp (Cannabis sativaL.) DNA sample from North West China.
Genet Resour Crop Evol 55:481– 485
Nesom GL (2011) Toward consistency of taxonomic rank in wild/domesticated Cucurbitaceae.
Phytoneuron 13:1– 33
Orr J, Starodub ME (1999) Industrial hemp risk assessment. Product Safety Bureau, Health,
Canada, Ottawa
Padial JM, de la Riva I (2006) Taxonomic inflation and the stability of species lists: the perils of
ostrich’s behavior. Syst Biol 55:859– 867
Pickens JT (1981) Sedative activity of cannabis in relation to itsD^1 -trans-tetrahydrocannabinol and
cannabidiol content. Br J Pharmacol 72:649– 656
Pickersgill B, ChacónSánchez MI, Debouck DG (2003) Multiple domestications and their
taxonomic consequences: the example ofPhaseolus vulgaris. Schr Genet Ressour 22:71– 83
Piluzza G, Delogu G, Cabras A, Marceddu S, Bullitta S (2013) Differentiation betweenfiber and
drug types of hemp (Cannabis sativa L.) from a collection of wild and domesticated
accessions. Genet Resour Crop Evol 60:2331– 2342
Piomelli D, Russo EB (2016) TheCannabis sativaversusCannabis indicadebate: an interview
with Ethan Russo, MD. Cannabis Cannabinoid Res 1(1):44– 46
Potter D (2009) The propagation, characterisation and optimisation ofCannabis sativaL. as a
phytopharmaceutical. King’s College, London (PhD thesis) http://www.gwpharm.com/
publications-1.aspx
Qaiser M (1973) Cannabaceae. In: Nasir E, Ali SI (eds) Flora of West Pakistan, issue 44.
University of Karachi, Karachi, pp 1– 3
Robinson BB (1935) Hemp. USDA Farmers’Bulletin No. 1935. U.S. Department of Agriculture,
Washington (Revised 1952)
Ross SA, Mehmedic Z, Murphy TP, ElSohly MA (2000) GC-MS analysis of the totalD^9 -THC
content of both drug- andfiber-typeCannabisseeds. J Anal Toxicol 24:715– 717
Rowan MG, Fairbairn JW (1977) Cannabinoid patterns in seedlings ofCannabis sativaand their
use in the determination of chemical race. J Pharm Pharmacol 29:491– 494
Rubin V, Comitas L (eds) (1975) Ganja in Jamaica: a medical anthropological study of chronic
marijuana use. Mouton, The Hague
Russo EB (2004) History of cannabis as a medicine. In: Guy GW, Whittle BA, Robson PJ (eds) The
medicinal uses of cannabis and cannabinoids. Pharmaceutical Press, London, pp 1– 16
Russo EB (2007) History of cannabis and its preparations in saga, science, and sobriquet. Chem
Biodiversity 4:1614– 1648
Russo EB (2011) Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid
entourage effects. Br J Pharmacol 163:1344– 1364
Russo EB (2014) The pharmacological history of cannabis. In: Pertwee RG (ed) Handbook of
cannabis. Oxford University Press, Oxford, pp 23– 43
1 Classification ofCannabis sativaL. in Relation... 59